Can topical ketorolac 0.5% improve the function of Ahmed® glaucoma drainage devices?

Ophthalmic Surg Lasers Imaging. 2011 May-Jun;42(3):190-5. doi: 10.3928/15428877-20110324-03. Epub 2011 Mar 31.

Abstract

Background and objective: To determine whether postoperative use of topical ketorolac tromethamine 0.5% affects intraocular pressure (IOP) following Ahmed glaucoma drainage device (New World Medical, Inc., Rancho Cucamonga, CA) implantation.

Patients and methods: Patients undergoing Ahmed implantation at the University of Michigan from January 2002 to June 2008 were reviewed. Fourteen eyes received ketorolac after surgery; 50 eyes did not. Preoperative and postoperative IOP and glaucoma medications were recorded for both groups; the two-sided Student's t test was used to compare these parameters.

Results: Mean preoperative IOP was similar in the two groups (35.1 ± 11.9 vs 37.0 ± 12.2 mm Hg; P = .60). At postoperative month 6, the ketorolac group had significantly lower IOP compared with the no ketorolac group (13.1 ± 3.7 vs 19.5 ± 9.3 mm Hg, respectively; P = .0003). There was no difference in the number of glaucoma medications postoperatively between the two groups.

Conclusion: Ketorolac may lead to lower postoperative IOP following Ahmed implantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Female
  • Follow-Up Studies
  • Glaucoma / drug therapy
  • Glaucoma / surgery*
  • Glaucoma Drainage Implants*
  • Humans
  • Intraocular Pressure / drug effects*
  • Ketorolac Tromethamine / administration & dosage*
  • Male
  • Middle Aged
  • Postoperative Care
  • Tonometry, Ocular
  • Visual Acuity / physiology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ketorolac Tromethamine